NEW DELHI, March 4, 2026 — Osstem Implant, the world’s largest dental implant company by sales volume, is accelerating its push to become the “Global No. 1 Dental Company” by strengthening its manufacturing footprint and tightening quality control worldwide.
The company has completed what it calls a “Global 4-Region Manufacturing Belt” with the full-scale operation of its new production base in Brazil, joining existing facilities in South Korea, the United States and China. Osstem said its annual global output now exceeds 22 million implant sets, enabling it to meet rising demand across key markets.
In 2025, Osstem reinforced its innovation pipeline with the completion of the “Triple Tower,” a research and development complex in Songdo International City, South Korea. The company also expanded its presence in the Americas by acquiring Implacil, Brazil’s third-largest implant maker, and enlarging its production plant in Pennsylvania.
Central to Osstem’s global expansion is what it describes as an “uncompromising quality” strategy. The company applies internal standards that it says exceed international Good Manufacturing Practice (GMP) requirements. It maintains a defect rate target of below 100 parts per million, equivalent to fewer than one defective unit per 10,000 products.
To ensure consistency, Osstem operates a six-major key process management system and a five-stage inspection framework covering self-inspection, machining, surface treatment, incoming materials and final shipment. Its facilities include cleanrooms and deionized water production systems, supported by a real-time quality management platform that responds to customer feedback.
Osstem has obtained multiple international certifications, including Korea’s KGMP, U.S. FDA clearance, Europe’s MDR, Japan’s QMS and China’s CFDA approvals, underscoring regulatory compliance in major markets.
The company invests more than 10% of its annual revenue in research and development. Around 900 researchers work across 15 specialized institutes within its central research organization, focusing on implants, equipment, materials, orthodontics and digital dentistry. Osstem positions itself as a total solutions provider rather than solely an implant manufacturer.
At AEEDC Dubai 2026, a major dental exhibition held in January, Osstem’s SOI implants and digital solutions drew attention from international clinicians, who cited their potential to reduce healing time.
An Osstem official said the company aims to reach 3 trillion won in annual sales by 2028, driven by strict quality management and sustained R&D investment.